Global Gene Therapy Drugs Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Gene Therapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Neuromuscular Disease
  • 1.3.3 Genetic Disease
  • 1.3.4 Other
• 1.4 Market by Application
  • 1.4.1 Global Gene Therapy Drugs Market Share by Application: 2020 VS 2026
  • 1.4.2 Hospital
  • 1.4.3 Pharmacy
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Gene Therapy Drugs Market Perspective (2015-2026)
• 2.2 Gene Therapy Drugs Growth Trends by Regions
  • 2.2.1 Gene Therapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gene Therapy Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Gene Therapy Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Gene Therapy Drugs Industry Dynamic
  • 2.3.1 Gene Therapy Drugs Market Trends
  • 2.3.2 Gene Therapy Drugs Market Drivers
  • 2.3.3 Gene Therapy Drugs Market Challenges
  • 2.3.4 Gene Therapy Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gene Therapy Drugs Players by Market Size
  • 3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2015-2020)
• 3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
• 3.4 Global Gene Therapy Drugs Market Concentration Ratio
  • 3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2019
• 3.5 Key Players Gene Therapy Drugs Area Served
• 3.6 Key Players Gene Therapy Drugs Product Solution and Service
• 3.7 Date of Enter into Gene Therapy Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Drugs Breakdown Data by Type

• 4.1 Global Gene Therapy Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2021-2026)

5 Gene Therapy Drugs Breakdown Data by Application

• 5.1 Global Gene Therapy Drugs Historic Market Size by Application (2015-2020)
• 5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Gene Therapy Drugs Market Size (2015-2026)
• 6.2 North America Gene Therapy Drugs Market Size by Type (2015-2020)
• 6.3 North America Gene Therapy Drugs Market Size by Application (2015-2020)
• 6.4 North America Gene Therapy Drugs Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Gene Therapy Drugs Market Size (2015-2026)
• 7.2 Europe Gene Therapy Drugs Market Size by Type (2015-2020)
• 7.3 Europe Gene Therapy Drugs Market Size by Application (2015-2020)
• 7.4 Europe Gene Therapy Drugs Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Therapy Drugs Market Size (2015-2026)
• 8.2 Asia-Pacific Gene Therapy Drugs Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Gene Therapy Drugs Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Gene Therapy Drugs Market Size (2015-2026)
• 9.2 Latin America Gene Therapy Drugs Market Size by Type (2015-2020)
• 9.3 Latin America Gene Therapy Drugs Market Size by Application (2015-2020)
• 9.4 Latin America Gene Therapy Drugs Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Therapy Drugs Market Size (2015-2026)
• 10.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Gene Therapy Drugs Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 F. Hoffmann-La Roche AG
  • 11.1.1 F. Hoffmann-La Roche AG Company Details
  • 11.1.2 F. Hoffmann-La Roche AG Business Overview
  • 11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
  • 11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2015-2020))
  • 11.1.5 F. Hoffmann-La Roche AG Recent Development
• 11.2 Novartis International AG
  • 11.2.1 Novartis International AG Company Details
  • 11.2.2 Novartis International AG Business Overview
  • 11.2.3 Novartis International AG Gene Therapy Drugs Introduction
  • 11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.2.5 Novartis International AG Recent Development
• 11.3 Gilead Sciences, Inc.
  • 11.3.1 Gilead Sciences, Inc. Company Details
  • 11.3.2 Gilead Sciences, Inc. Business Overview
  • 11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
  • 11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.3.5 Gilead Sciences, Inc. Recent Development
• 11.4 Ultragenyx Pharmaceutical，Inc.
  • 11.4.1 Ultragenyx Pharmaceutical，Inc. Company Details
  • 11.4.2 Ultragenyx Pharmaceutical，Inc. Business Overview
  • 11.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Introduction
  • 11.4.4 Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.4.5 Ultragenyx Pharmaceutical，Inc. Recent Development
• 11.5 Applied Genetic Technologies Corp
  • 11.5.1 Applied Genetic Technologies Corp Company Details
  • 11.5.2 Applied Genetic Technologies Corp Business Overview
  • 11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
  • 11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.5.5 Applied Genetic Technologies Corp Recent Development
• 11.6 Audentes Therapeutics
  • 11.6.1 Audentes Therapeutics Company Details
  • 11.6.2 Audentes Therapeutics Business Overview
  • 11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
  • 11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.6.5 Audentes Therapeutics Recent Development
• 11.7 BioMarin Pharmaceutical
  • 11.7.1 BioMarin Pharmaceutical Company Details
  • 11.7.2 BioMarin Pharmaceutical Business Overview
  • 11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
  • 11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.7.5 BioMarin Pharmaceutical Recent Development
• 11.8 Bluebird Bio
  • 11.8.1 Bluebird Bio Company Details
  • 11.8.2 Bluebird Bio Business Overview
  • 11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
  • 11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.8.5 Bluebird Bio Recent Development
• 11.9 Nightstar Therapeutics
  • 11.9.1 Nightstar Therapeutics Company Details
  • 11.9.2 Nightstar Therapeutics Business Overview
  • 11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
  • 11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.9.5 Nightstar Therapeutics Recent Development
• 11.10 Sangamo Therapeutics
  • 11.10.1 Sangamo Therapeutics Company Details
  • 11.10.2 Sangamo Therapeutics Business Overview
  • 11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
  • 11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
  • 11.10.5 Sangamo Therapeutics Recent Development
• 11.11 Spark Therapeutics
  • 10.11.1 Spark Therapeutics Company Details
  • 10.11.2 Spark Therapeutics Business Overview
  • 10.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
  • 10.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
  • 10.11.5 Spark Therapeutics Recent Development
• 11.12 uniQure
  • 10.12.1 uniQure Company Details
  • 10.12.2 uniQure Business Overview
  • 10.12.3 uniQure Gene Therapy Drugs Introduction
  • 10.12.4 uniQure Revenue in Gene Therapy Drugs Business (2015-2020)
  • 10.12.5 uniQure Recent Development
• 11.13 VBL Therapeutics
  • 10.13.1 VBL Therapeutics Company Details
  • 10.13.2 VBL Therapeutics Business Overview
  • 10.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
  • 10.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
  • 10.13.5 VBL Therapeutics Recent Development
• 11.14 Voyager Therapeutics
  • 10.14.1 Voyager Therapeutics Company Details
  • 10.14.2 Voyager Therapeutics Business Overview
  • 10.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
  • 10.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
  • 10.14.5 Voyager Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer